Convertibles Calendar: Rovi to price $300 million of convertible notes

February 26

ROVI CORP.:

• $300 million of five-year convertible notes

• $45 million greenshoe

• Talked 0.25%-0.75%, up 22.5%-27.5%

• Rule 144A

• Joint bookrunners Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC and BofA Merrill Lynch

• Barclays is co-manager

• Contingent conversion

• Non-callable

• Concurrent call spread

• Proceeds to $100.1 million to repay borrowings and accrued interest under its revolving credit facility, about $25 million will be used to repurchase common stock, and a portion will be used to fund the net cost of the call spread

• Santa Clara, Calif.-based software and internet media company

• Nasdaq: ROVI

On The Horizon

FRONTIER COMMUNICATIONS CORP.:

• Convertible debt

• Concurrent with equity and other debt

• Backed by commitment for two bridge loans for a total amount of $11,594,000,000

• Proceeds to fund the acquisition of certain wireline operations from Verizon Communications

• Closing expected in the first half of 2016

• Stamford, Conn.-based wireline telecommunications provider

• NYSE listing: FTR

CARNIVAL GROUP INTERNATIONAL HOLDING LTD.:

• Unsecured senior convertible bonds

• Bookrunner Deutsche Bank AG, Hong Kong Branch

• Regulation S

• Concurrent equity swap with Deutsche Bank AG, London Branch as equity swap counterparty

• Proceeds to fund existing and new projects; entry into the equity swap; and for working capital and other general corporate purposes

• Bermuda-based investment holding company engaged in leisure and consumption businesses

• Hong Kong: 00996

PLATFORM SPECIALTY PRODUCTS CORP.:

• Convertible securities as part of a funding package of cash, convertibles, debt and equity

• Proceeds to fund $3.51 billion acquisition of Arysta LifeScience Ltd., a Tokyo-based provider of agrochemical and biological products

• Barclays, Credit Suisse Securities (USA) LLC, Nomura Securities International LLC and UBS AG acted as M&A advisers and have committed financing for the acquisition

• Anticipated closing in first quarter 2015

• Miami-based specialty chemicals company

• NYSE: PAH

INTERNATIONAL CALENDAR

February 26

ABENGOA SA:

• About $300 million two-year exchangeables

• Regulation S and Rule 144A

• Exchangeable into Abengoa Yield plc

• Talked 3.375%-5.125%, up 20%-25%

• Joint bookrunners Citigroup Global Markets Inc., BofA Merrill Lynch, HSBC and Morgan Stanley

• Non-callable

• Takeover protection via standard Euromarket make whole

• Proceeds to strengthen liquidity and repay short-term debt

• Seville, Spain-based industrial and technology group

• Spain: ABG

February 27

TiGenix NV:

• €25 million three-year convertibles

• Regulation S

• Talked 8%-9%, up 25%-30%

• Bookrunner Nomura International plc

• Non-callable for two years, then provisionally callable at 130% price hurdle

• Proceeds to fund clinical development of cell therapy products

• Belgium-based biomedical company

• Brussels: TIG

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.